Evidence map›Paper›PMID 21715000›Full record

ArticleLancet (London, England)2011

Arresting type 1 diabetes after diagnosis: GAD is not enough.

Chantal Mathieu, Pieter Gillard

Registry-linked trialAbstract readComment
PubMed Publisher
In one paragraph

Article in Lancet (London, England), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03011008 (Effect of Liraglutide as Additional Treatment to Insulin in Patients With Autoimmune Diabetes Mellitus), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03011008 phase4unknown statusstarted 2017, after this paper: background citation

Effect of Liraglutide as Additional Treatment to Insulin in Patients With Autoimmune Diabetes Mellitus

Ran2017Enrolled20Registered outcomes6Posted comparisons0ConditionsAutoimmune Diabetes, Type 1 Diabetes MellitusArmsInsulin, liraglutide
PMID 24003936PMID 26997114other papers from this trial
Open the trial in the graph
3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Chantal MathieuLaboratory and Clinic of Experimental Medicine and Endocrinology, University Hospital Leuven, Catholic University of Leuven, Leuven 3000, Belgium. chantal.mathieu@uzleuven.be
Pieter Gillard

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ImmunotherapyAluminum HydroxideAnimalsBiomedical ResearchC-PeptideDiabetes Mellitus, Type 1Disease Models, AnimalGlutamate DecarboxylaseHumansAluminum HydroxideC-PeptideGlutamate Decarboxylase

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.